Home › Medulloblastoma › Texas
Pag-aaral pangklinika para sa Medulloblastoma sa Texas
8 pag-aaral para sa Medulloblastoma ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Nagre-recruitPhase 2
59 Months · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
Nagre-recruitPhase 2
Hanggang edad 19 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 50 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
Nagre-recruitPhase 2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- at 4 pa
Nagre-recruitPhase 3
Edad 4 hanggang 21 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT04696029Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.